[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635800":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":11,"locations":11,"responsibleParty":30,"collaborators":11,"id":34,"slug":35,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":38,"acronym":11,"eligibilityCriteria":39,"healthyVolunteers":36,"sex":40,"minAge":41,"maxAge":42,"enrollmentInfo":43,"targetDuration":11,"studyType":46,"phases":47,"briefSummary":49,"conditions":50,"keywords":52,"overallStatus":56,"whyStopped":11,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":11},{"fullName":5,"class":6},"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"experimental group","EXPERIMENTAL",null,[13,14],"Drug: Shouhui Tongbian Capsules","Drug: Pancreatin Enteric-Coated Capsules",{"label":16,"type":17,"description":11,"interventionNames":18},"control group","ACTIVE_COMPARATOR",[14],[20,27],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Shouhui Tongbian Capsules","Shouhui Tongbian Capsules are taken orally, 2 capsules per dose, 3 times daily;Pancreatin enteric-coated capsules are administered at the clinically conventional dosage; for a continuous period of 12 weeks.",[9],[26],"Pancreatin Enteric-Coated Capsules",{"type":21,"name":26,"description":28,"armGroupLabels":29,"otherNames":11},"Pancreatin enteric-coated capsules are administered at the clinically conventional dosage,for a continuous period of 12 weeks.",[16,9],{"type":31,"investigatorFullName":32,"investigatorTitle":33,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Wu Chuanxing","Associate Chief Physician","100635800","phase-4-a-prospective-non-randomized-controlled-interventional-study-on-the-effect-of-shouhui-tongbian-capsules-combined-with-pancreatin-enteric-coated-capsules-on-pancreatic-exocrine-function-in-patients-after-curative-resection-for-pancreatic-cancer-100635800",false,"NCT07557394","A Prospective Non-randomized Controlled Interventional Study on the Effect of Shouhui Tongbian Capsules Combined With Pancreatin Enteric-coated Capsules on Pancreatic Exocrine Function in Patients After Curative Resection for Pancreatic Cancer","Inclusion Criteria:\n\n1. Age: 18-80 years old;\n2. Pathologically confirmed pancreatic cancer and underwent pancreaticoduodenectomy(involved removing 50% of the pancreas, leaving 50% of the pancreas, ensuring balanced grouping);\n3. Presence of EPI symptoms (such as steatorrhea) and\u002For constipation (Bristol type 1-2, with \\\u003C3 bowel movements per week);\n4. Have informed consent and be proficient in using smartphone apps;\n5. Patients who are intended to receive treatment with either Daitong Capsules or Shouhui Tongbian Capsules, or both;\n6. The patient's condition is stable and suitable for participation in this study, as confirmed by investigator;\n7. Willing and able to follow the medication and follow-up plan specified in the study protocol, with an expected medication adherence rate of over 80%.\n\nExclusion Criteria:\n\n1. Allergic to pancreatic enzyme (porcine-derived protein allergy) or any ingredient of Shouhui Tongbian Capsules;\n2. Have a history of liver damage caused by Polygonum multiflorum;\n3. Combined with intestinal obstruction, severe hepatic and renal insufficiency (Child-Pugh Class C, eGFR \\\u003C 30 ml\u002Fmin), etc;\n4. Pregnant or lactating women;\n5. Psychological cognitive impairment.\n6. It is expected that the 12-weeks follow-up will not be completed.","ALL","18 Years","80 Years",{"count":44,"type":45},80,"ESTIMATED","INTERVENTIONAL",[48],"PHASE4","Exploratory evaluation comparing the addition of Shouhui Constipation Capsules to standard pancreatic enzyme therapy for improving exocrine pancreatic function in patients after pancreaticoduodenectomy.",[51],"Pancreatic Cancer",[53,54,55],"pancreaticoduodenectomy","PD","Pancreatic exocrine function","NOT_YET_RECRUITING","2026-04-22",{"date":59,"type":60},"2026-04-29","ACTUAL",{"date":62,"type":45},"2026-05-01",{"date":64,"type":45},"2028-04-30",{"name":5,"class":6}]